Analyst Price Targets — AMWL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 13, 2026 9:47 am | Jailendra Singh | Truist Financial | $12.00 | $12.65 | StreetInsider | American Well Corp. (AMWL) PT Raised to $12 at Truist Securities |
| August 5, 2026 12:26 pm | — | Morgan Stanley | $13.00 | $12.96 | TheFly | Amwell price target raised to $13 from $6.50 at Morgan Stanley |
| August 5, 2026 11:04 am | — | UBS | $11.00 | $10.44 | TheFly | Amwell price target raised to $11 from $6.50 at Stifel |
| July 17, 2026 10:19 am | Stephen Baxter | Wells Fargo | $16.00 | $10.95 | TheFly | Amwell price target raised to $16 from $9 at Wells Fargo |
| June 8, 2026 11:04 am | Jailendra Singh | Truist Financial | $7.50 | $8.62 | StreetInsider | Truist Securities Reiterates Hold Rating on American Well Corp. (AMWL) |
| May 6, 2026 11:28 am | — | Morgan Stanley | $6.50 | $6.41 | TheFly | Amwell price target raised to $6.50 from $6 at Morgan Stanley |
| February 13, 2026 12:14 pm | David Grossman | Stifel Nicolaus | $5.00 | $4.43 | TheFly | Amwell price target lowered to $5 from $6 at Stifel |
| November 5, 2025 12:31 pm | — | Stifel Nicolaus | $6.00 | $4.71 | TheFly | Amwell price target lowered to $6 from $8 at Stifel |
| January 6, 2023 8:45 am | — | Morgan Stanley | $87.09 | $46.16 | Benzinga | Morgan Stanley Maintains Overweight on American Well, Lowers Price Target to $6 |
| September 7, 2022 4:36 am | Jessica Tassan | Piper Sandler | $90.72 | $78.74 | TheFly | Amwell price target lowered to $5 from $6 at Piper Sandler |
Latest News for AMWL
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced the Department of Veterans Affairs (VA) has declared its intent for the Company to deploy its virtual health platform within the VA enterprise and help power the modernization of the VA's digital health infrastructure.
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell's ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician…
BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:
American Well (AMWL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
American Well (AMWL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AMWL.
U.S. House Trading
No House trades found for AMWL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.